Pulse Biosciences, Inc.PLSENASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+17.6%
5Y CAGR+9.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+17.6%/yr
vs +5.4%/yr prior
5Y CAGR
+9.3%/yr
Recent acceleration
Acceleration
+12.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $76.22M | +35.5% |
| 2024 | $56.26M | +32.8% |
| 2023 | $42.37M | -9.5% |
| 2022 | $46.81M | -25.1% |
| 2021 | $62.46M | +27.8% |
| 2020 | $48.87M | +1.9% |
| 2019 | $47.95M | +26.3% |
| 2018 | $37.96M | +47.1% |
| 2017 | $25.81M | +169.3% |
| 2016 | $9.59M | - |